Skip Navigation
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

News From NIAID-Supported Institutions

Below are links to press releases about NIAID-funded research from some of the institutions we support.

November 2014

Inhaled Ebola Vaccine May Offer Long-Term Protection from Virus 
November 3, 2014—The University of Texas at Austin

New Technique Efficiently Turns Antibodies Into Highly Tuned “Nanobodies” 
November 2, 2014—Rockefeller University

October 2014

Improved Mouse Model Will Accelerate Research on Potential Ebola Vaccines, Treatments 
October 31, 2014—University of North Carolina at Chapel Hill
Study: “Wimpy” Antibody Protects Against Kidney Disease in Mice 
October 31, 2014—University of Cincinnati

Mouse Model Suggests Varied Genetic Dispositions to Ebola 
October 30, 2014—University of Washington
UC Davis Scientists Discover Exact Receptor for DEET That Repels Mosquitoes 
October 27, 2014—University of California, Davis

Divide and Conquer: Novel Trick Helps Rare Pathogen Infect Healthy People   
October 17, 2014—University of Birmingham

Scientific Breakthrough Will Help Design the Antibiotics of the Future   
October 17, 2014—University of Bristol

Study Models Ways to Cut Mexico’s HIV Rates 
October 15, 2014—Brown University

Antiretroviral Therapy Benefits HIV-infected Stimulant Users, UCSF Study Shows 
October 10, 2014—University of California - San Francisco

School of Medicine Begins Ebola Vaccine Trials 
October 9, 2014—University of Maryland School of Medicine (UM SOM)

UAB Part of NIH-Funded Research Consortia Studying More Than 200 Rare Diseases   
October 9, 2014—University of Alabama at Birmingham

Scientists Discover Pain Receptor on T-Cells 
October 5, 2014—University of California, San Diego School of Medicine

Gut Bacteria Are Protected by Host During Illness 
October 2, 2014—University of Chicago

September 2014

Surprising Diversity of Antibody Family Provides Clues for HIV Vaccine Design 
September 29, 2014—The Scripps Research Institute

Geisel Researchers Contribute to Study of Trained Immunity 
September 26, 2014—Geisel School of Medicine at Dartmouth
Dry Roasting Could Help Trigger Peanut Allergy 
September 22, 2014—Oxford University

Penn Researchers Describe New Cancer Drug Target Involving Lipid Chemical Messengers 
September 19, 2014—Perelman School of Medicine, University of Pennsylvania

Research Predicts Possible 6,800 New Ebola Cases This Month 
September 19, 2014—Arizona State University

Research Yields a Game Changer for Improving Understanding of Ebola and Great Apes 
September 18, 2014—The Wildlife Conservation Society

Professor Dennis Burton: In Search of an Effective HIV/AIDS Vaccine 
September 15, 2014—The Scripps Research Institute
New Insights in Survival Strategies of Bacteria   
September 14, 2014—VIB (the Flanders Institute for Biotechnology)
Geneva & Partners in Development of Ebola Drug 
September 12, 2014—The Geneva Foundation
Study Sheds Light on Asthma and Respiratory Viruses   
September 9, 2014—Washington University School of Medicine in St. Louis
Unusual Immune Cell Needed to Prevent Oral Thrush, Pitt Researchers Find 
September 8, 2014—University of Pittsburgh School of Medicine
Suppressing Food Allergies Quickly Is the Goal of UC Research Team 
September 8, 2014—University of Cincinnati College of Medicine
Team Identifies Important Regulators of Immune Cell Response   
September 8, 2014—The Scripps Research Institute
MCW Scientists to Investigate New Therapy for Obstructive Lung Disease 
September 4, 2014—The Medical College of Wisconsin

Avian Influenza Virus Isolated in Harbor Seals Poses a Threat to Humans 
September 4, 2014—St. Jude Children’s Research Hospital
Leaky Gut—A Source of Non-AIDS Complications in HIV-Positive Patients 
September 3, 2014—Case Western Reserve University School of Medicine

War Between Bacteria and Phages Benefits Humans   
September 2, 2014—Tufts University

August 2014

Discovery Reveals how Bacteria Distinguish Harmful Versus Helpful Viruses 
August 31, 2014—The Rockefeller University

Drug Shows Promise Against Sudan Strain of Ebola in Mice 
August 28, 2014—Albert Einstein College of Medicine

Synthesis Produces New Antibiotic 
August 28, 2014—Rice University

Key to Universal Flu Vaccine: Embrace the Unfamiliar 
August 27, 2014—Emory Vaccine Center
Fungus Deadly to AIDS Patients Found to Grow on Trees 
August 21, 2014—Duke University School of Medicine

Some Anti-Inflammatory Drugs Affect More Than Their Targets
August 21, 2014—Johns Hopkins University School of Medicine

Food Allergies More Widespread Among Inner-City Children 
August 14, 2014—Johns Hopkins Medicine

Gut Flora Influences HIV Immune Response 
August 13, 2014—Duke Medicine

OMRF Receives $14.5 Million Grant to Continue Anthrax Studies 
August 13, 2014—Oklahoma Medical Research Foundation

Developing A Better Test For Lyme Disease Diagnosis 
August 6, 2014—RareCyte, Inc.

July 2014

Molecule Enhances Copper’s Lethal Punch Against Microbes 
July 31, 2014—Duke University

Researchers Uncover Clues to Flu’s Mechanisms 
July 31, 2014—Rice University
"Viral Fitness" Discovery Defines HIV Vulnerability 
July 11, 2014—Emory University Health Sciences
Recalled Yogurt Contained Highly Pathogenic Mold 
July 8, 2014—Duke University
NYU Researchers Tackle Racial/Ethnic Disparities in HIV Medical Studies   
July 7, 2014—New York University College of Nursing
Researchers Learn How Beryllium Causes Deadly Lung Disease 
July 3, 2014—National Jewish Health
Screening Children for Celiac Disease 
July 3 2014—University of Colorado School of Medicine

Institute for Genome Sciences Awarded NIAID Grant 
July 1, 2014—University of Maryland School of Medicine

Sorrento Awarded up to $2.6 Million from the National Institutes of Health (NIH) for the Development of New Anti-bacterial Bispecific Antibodies and Antibody Formulated Drug Conjugates 
July 1, 2014—Sorrento Therapeutics, Inc.



Last Updated November 20, 2014

Last Reviewed September 12, 2014